Federation des caisses Desjardins du Quebec’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $69.7M | Buy |
2,480,449
+141,410
| +6% | +$3.76M | 0.25% | 62 |
|
|
2025
Q4 | $58.2M | Buy |
2,339,039
+16,130
| +0.7% | +$407K | 0.22% | 75 |
|
|
2025
Q3 | $59.2M | Buy |
2,322,909
+179,249
| +8% | +$4.42M | 0.23% | 73 |
|
|
2025
Q2 | $52M | Buy |
2,143,660
+49,066
| +2% | +$1.14M | 0.23% | 76 |
|
|
2025
Q1 | $53.1M | Buy |
2,094,594
+612,940
| +41% | +$16M | 0.26% | 71 |
|
|
2024
Q4 | $39.3M | Sell |
1,481,654
-665,216
| -31% | -$18M | 0.2% | 88 |
|
|
2024
Q3 | $62.1M | Buy |
2,146,870
+350,222
| +19% | +$10.2M | 0.31% | 54 |
|
|
2024
Q2 | $50.3M | Buy |
1,796,648
+18,855
| +1% | +$519K | 0.27% | 65 |
|
|
2024
Q1 | $49.4M | Buy |
1,777,793
+594,216
| +50% | +$16.5M | 0.36% | 58 |
|
|
2023
Q4 | $34.1M | Sell |
1,183,577
-1,827
| -0.2% | -$55.2K | 0.32% | 64 |
|
|
2023
Q3 | $39.3M | Buy |
1,185,404
+167,483
| +16% | +$5.92M | 0.41% | 57 |
|
|
2023
Q2 | $37.3M | Buy |
1,017,921
+90,766
| +10% | +$3.53M | 0.37% | 58 |
|
|
2023
Q1 | $37.8M | Sell |
927,155
-3,161
| -0.3% | -$137K | 0.42% | 55 |
|
|
2022
Q4 | $47.7M | Sell |
930,316
-6,534
| -0.7% | -$313K | 0.56% | 42 |
|
|
2022
Q3 | $41M | Sell |
936,850
-17,107
| -2% | -$831K | 0.49% | 50 |
|
|
2022
Q2 | $50M | Buy |
953,957
+18,946
| +2% | +$965K | 0.56% | 45 |
|
|
2022
Q1 | $48.4M | Buy |
935,011
+4,612
| +0.5% | +$239K | 0.47% | 49 |
|
|
2021
Q4 | $54.9M | Buy |
930,399
+4,783
| +0.5% | +$237K | 0.54% | 47 |
|
|
2021
Q3 | $39.8M | Sell |
925,616
-179,001
| -16% | -$7.93M | 0.41% | 53 |
|
|
2021
Q2 | $43.3M | Buy |
1,104,617
+277,270
| +34% | +$10.8M | 0.44% | 52 |
|
|
2021
Q1 | $30M | Buy |
827,347
+69,306
| +9% | +$2.46M | 0.33% | 62 |
|
|
2020
Q4 | $27.9M | Buy |
758,041
+137,153
| +22% | +$5.03M | 0.34% | 64 |
|
|
2020
Q3 | $21.6M | Sell |
620,888
-55,931
| -8% | -$1.96M | 0.3% | 73 |
|
|
2020
Q2 | $21M | Buy |
676,819
+57,093
| +9% | +$1.94M | 0.32% | 72 |
|
|
2020
Q1 | $19.2M | Buy |
619,726
+102,128
| +20% | +$3.48M | 0.34% | 65 |
|
|
2019
Q4 | $19.2M | Buy |
517,598
+86,499
| +20% | +$3.08M | 0.27% | 66 |
|
|
2019
Q3 | $14.7M | Buy |
431,099
+73,394
| +21% | +$2.67M | 0.21% | 82 |
|
|
2019
Q2 | $14.7M | Sell |
357,705
-29,449
| -8% | -$1.17M | 0.22% | 86 |
|
|
2019
Q1 | $15.6M | Sell |
387,154
-437,236
| -53% | -$17.5M | 0.24% | 79 |
|
|
2018
Q4 | $34.1M | Sell |
824,390
-177,522
| -18% | -$7.37M | 0.58% | 37 |
|
|
2018
Q3 | $41.9M | Sell |
1,001,912
-27,314
| -3% | -$1.05M | 0.61% | 34 |
|
|
2018
Q2 | $35.4M | Buy |
1,029,226
+34,615
| +3% | +$1.18M | 0.53% | 38 |
|
|
2018
Q1 | $33.5M | Buy |
994,611
+61,300
| +7% | +$2.11M | 0.52% | 38 |
|
|
2017
Q4 | $32.1M | Buy |
933,311
+1,224
| +0.1% | +$41.7K | 0.48% | 42 |
|
|
2017
Q3 | $31.6M | Buy |
932,087
+5,374
| +0.6% | +$173K | 0.5% | 37 |
|
|
2017
Q2 | $29.5M | Buy |
926,713
+891,128
| +2,504% | +$28.1M | 0.48% | 38 |
|
|
2017
Q1 | $1.15M | Buy |
+35,585
| New | +$1.12M | 0.02% | 522 |
|
Other funds holding PFE
VCM
VPM
Federation des caisses Desjardins du Quebec's PFE Position: Q1 2026 in Review
Federation des caisses Desjardins du Quebec increased its Pfizer (PFE) stake by 6% in Q1 2026, buying an estimated $3.76M and bringing the position to 2,480,449 shares worth $69.7M. The position accounts for 0.25% of the portfolio, ranked #62.
Federation des caisses Desjardins du Quebec first reported a position in PFE in Q1 2017 and has held it in 37 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Federation des caisses Desjardins du Quebec held 2,480,449 shares of Pfizer worth $69.7M as of Q1 2026.
- Federation des caisses Desjardins du Quebec bought 141,410 Pfizer shares in Q1 2026, an estimated $3.76M.
- Pfizer made up 0.25% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #62 holding.
- Federation des caisses Desjardins du Quebec first reported a position in Pfizer in Q1 2017 and has held it in 37 quarters since.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.